Cargando…
Galectin‐3 and Risk of Heart Failure and Death in Blacks and Whites
BACKGROUND: The association between galectin‐3 and heart failure (HF) or death is well established for white, but not for black, adults. METHODS AND RESULTS: Galectin‐3 was measured in 1809 participants (1375 white, 434 black), enrolled in a substudy of the Atherosclerosis Risk in Communities (ARIC)...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4889181/ https://www.ncbi.nlm.nih.gov/pubmed/27178204 http://dx.doi.org/10.1161/JAHA.115.003079 |
_version_ | 1782434960826695680 |
---|---|
author | McEvoy, John W. Chen, Yuan Halushka, Marc K. Christenson, Eric Ballantyne, Christie M. Blumenthal, Roger S. Christenson, Robert H. Selvin, Elizabeth |
author_facet | McEvoy, John W. Chen, Yuan Halushka, Marc K. Christenson, Eric Ballantyne, Christie M. Blumenthal, Roger S. Christenson, Robert H. Selvin, Elizabeth |
author_sort | McEvoy, John W. |
collection | PubMed |
description | BACKGROUND: The association between galectin‐3 and heart failure (HF) or death is well established for white, but not for black, adults. METHODS AND RESULTS: Galectin‐3 was measured in 1809 participants (1375 white, 434 black), enrolled in a substudy of the Atherosclerosis Risk in Communities (ARIC) observational cohort during 2004–2005. We used Cox proportional hazard models to estimate the adjusted association between galectin‐3 and outcomes. Analyses were conducted overall and by race category. Median (interquartile range) galectin‐3 levels were 13.4 (11.2–16.4) and 14.8 (12–17.6) ng/mL, in white and black participants, respectively. In the sample overall, galectin‐3 was not independently associated with HF or death over a maximum of 7.9 years. However, in race‐stratified analyses, galectin‐3 was independently associated with a composite of HF or death among whites (eg, hazard ratio 2.2, 95% CI 1.2–3.9, comparing Q4 versus Q1); but not among blacks (hazard ratio of 0.8 [0.4–1.8] for Q4 versus Q1, race interaction P=0.03). Associations between galectin‐3 and both outcomes analyzed individually also demonstrated similar racial differences. Furthermore, results were qualitatively similar with galectin‐3 modeled as a continuous exposure. In addition, galectin‐3 improved discrimination for the composite of HF or death among whites (increase in Harrell's C statistic from 0.729 to 0.735 [difference of +0.006], P=0.049), but not among blacks (0.696 to 0.695 [difference of −0.001], P=0.814). CONCLUSIONS: In contrast to whites, galectin‐3 may have limited prognostic utility for predicting HF and death in blacks. While our results require replication, they could reflect racial differences in the processes by which galectin‐3 mediates disease. |
format | Online Article Text |
id | pubmed-4889181 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-48891812016-06-09 Galectin‐3 and Risk of Heart Failure and Death in Blacks and Whites McEvoy, John W. Chen, Yuan Halushka, Marc K. Christenson, Eric Ballantyne, Christie M. Blumenthal, Roger S. Christenson, Robert H. Selvin, Elizabeth J Am Heart Assoc Original Research BACKGROUND: The association between galectin‐3 and heart failure (HF) or death is well established for white, but not for black, adults. METHODS AND RESULTS: Galectin‐3 was measured in 1809 participants (1375 white, 434 black), enrolled in a substudy of the Atherosclerosis Risk in Communities (ARIC) observational cohort during 2004–2005. We used Cox proportional hazard models to estimate the adjusted association between galectin‐3 and outcomes. Analyses were conducted overall and by race category. Median (interquartile range) galectin‐3 levels were 13.4 (11.2–16.4) and 14.8 (12–17.6) ng/mL, in white and black participants, respectively. In the sample overall, galectin‐3 was not independently associated with HF or death over a maximum of 7.9 years. However, in race‐stratified analyses, galectin‐3 was independently associated with a composite of HF or death among whites (eg, hazard ratio 2.2, 95% CI 1.2–3.9, comparing Q4 versus Q1); but not among blacks (hazard ratio of 0.8 [0.4–1.8] for Q4 versus Q1, race interaction P=0.03). Associations between galectin‐3 and both outcomes analyzed individually also demonstrated similar racial differences. Furthermore, results were qualitatively similar with galectin‐3 modeled as a continuous exposure. In addition, galectin‐3 improved discrimination for the composite of HF or death among whites (increase in Harrell's C statistic from 0.729 to 0.735 [difference of +0.006], P=0.049), but not among blacks (0.696 to 0.695 [difference of −0.001], P=0.814). CONCLUSIONS: In contrast to whites, galectin‐3 may have limited prognostic utility for predicting HF and death in blacks. While our results require replication, they could reflect racial differences in the processes by which galectin‐3 mediates disease. John Wiley and Sons Inc. 2016-05-13 /pmc/articles/PMC4889181/ /pubmed/27178204 http://dx.doi.org/10.1161/JAHA.115.003079 Text en © 2016 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley Blackwell. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial (http://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Original Research McEvoy, John W. Chen, Yuan Halushka, Marc K. Christenson, Eric Ballantyne, Christie M. Blumenthal, Roger S. Christenson, Robert H. Selvin, Elizabeth Galectin‐3 and Risk of Heart Failure and Death in Blacks and Whites |
title | Galectin‐3 and Risk of Heart Failure and Death in Blacks and Whites |
title_full | Galectin‐3 and Risk of Heart Failure and Death in Blacks and Whites |
title_fullStr | Galectin‐3 and Risk of Heart Failure and Death in Blacks and Whites |
title_full_unstemmed | Galectin‐3 and Risk of Heart Failure and Death in Blacks and Whites |
title_short | Galectin‐3 and Risk of Heart Failure and Death in Blacks and Whites |
title_sort | galectin‐3 and risk of heart failure and death in blacks and whites |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4889181/ https://www.ncbi.nlm.nih.gov/pubmed/27178204 http://dx.doi.org/10.1161/JAHA.115.003079 |
work_keys_str_mv | AT mcevoyjohnw galectin3andriskofheartfailureanddeathinblacksandwhites AT chenyuan galectin3andriskofheartfailureanddeathinblacksandwhites AT halushkamarck galectin3andriskofheartfailureanddeathinblacksandwhites AT christensoneric galectin3andriskofheartfailureanddeathinblacksandwhites AT ballantynechristiem galectin3andriskofheartfailureanddeathinblacksandwhites AT blumenthalrogers galectin3andriskofheartfailureanddeathinblacksandwhites AT christensonroberth galectin3andriskofheartfailureanddeathinblacksandwhites AT selvinelizabeth galectin3andriskofheartfailureanddeathinblacksandwhites |